Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0096 | 0.9 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |